Company Filing History:
Years Active: 2011-2015
Title: Jason D Modest: Innovator in Tranexamic Acid Formulations
Introduction
Jason D Modest is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on tranexamic acid. With a total of 9 patents to his name, Modest has developed innovative solutions aimed at improving patient outcomes.
Latest Patents
Among his latest patents, Modest has disclosed modified release oral tranexamic acid formulations. These formulations are designed to minimize adverse effects associated with tranexamic acid therapy, such as nausea and vomiting. One of his key innovations is an extended release formulation that incorporates waxes and polymers to prevent a bolus release of tranexamic acid in the stomach. Additionally, he has developed a delayed release formulation that utilizes polymers to delay the release of tranexamic acid until it reaches the less acidic environment of the intestines. These advancements enhance patient compliance by reducing the adverse effects of tranexamic acid therapy, particularly for conditions like heavy menstrual bleeding.
Career Highlights
Jason D Modest is currently associated with Ferring B.V., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Modest has collaborated with notable colleagues, including Keith A Moore and Ralph A Heasley. These partnerships have contributed to the development of his groundbreaking patents and innovations.
Conclusion
Jason D Modest stands out as a prominent inventor in the pharmaceutical field, particularly for his work on tranexamic acid formulations. His innovative approaches aim to improve patient experiences and outcomes in medical treatments.